Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2026-03-26 @ 3:14 PM
Ignite Modification Date: 2026-03-26 @ 3:14 PM
NCT ID: NCT07435961
Eligibility Criteria: Inclusion Criteria: * Adults aged between 18 and 65 years. Clinical diagnosis of carpal tunnel syndrome (CTS) based on physical examination findings, including positive Tinel and/or Phalen tests and hypoesthesia in the 3rd to 5th digits. Electrophysiologically confirmed mild-to-moderate carpal tunnel syndrome based on electromyography (EMG) findings. Exclusion Criteria: * Severe carpal tunnel syndrome confirmed electrophysiologically by electromyography (EMG). History of previous surgical intervention for carpal tunnel syndrome. Presence of other peripheral nerve entrapments (e.g., ulnar nerve entrapment, radial nerve entrapment). Electrophysiologically confirmed polyneuropathy or cervical radiculopathy/cervical discopathy. Rheumatologic diseases (e.g., rheumatoid arthritis, systemic lupus erythematosus). Diabetes mellitus (Type 1 or Type 2). Pregnancy. Presence of electronic implants such as cardiac pacemaker, cochlear implant, or implantable defibrillator. Active acute infection. History of malignancy. Receipt of physical therapy or rehabilitation for the wrist or surrounding area within the past 6 months. Corticosteroid injection to the wrist within the past 6 months. Hyperthyroidism or adrenal gland hyperfunction. Open growth plates (epiphyseal plates not closed). Paroxysmal neurological disorders (e.g., epilepsy). Myasthenia gravis. Regular use of pain medications such as pregabalin, duloxetine, or non-steroidal anti-inflammatory drugs (NSAIDs).
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 65 Years
Study: NCT07435961
Study Brief:
Protocol Section: NCT07435961